Federal Register Notice: FDA’s proposed collection of information “Adverse Experience Reporting for Licensed Biological Products; and General Records — 21 CFR Part 600,” has been submitted to the Office of Management and Budget for review and clearance under the Paperwork Reduction Act of 1995. To view this notice, click here.
